High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
By L. Licitra, F. Perrone, P. Bossi, S. Suardi, L. Mariani, R. Artusi, M. Oggionni, C. Rossini, G. Cantù, M. Squadrelli and 6 more. Journal of Clinical Oncology, 2006
668 citations recorded by the source corpus.
Subfields: Epidemiology, Oncology, Otorhinolaryngology
View Paper: https://www.semanticscholar.org/paper/4e0e758e01ef4fcf1b97a6fb9bc800e98a1d402e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Oncology
In Otorhinolaryngology
Citations in the corpus
- Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand? (2017, background): “Finally HPV-positive patients do well independently of treatment choice, as long as conforms to the standard of care [2,3,7].”
- Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysis (2007, background): “The risk Gillison et al.32 253 Fresh frozen: 200 (primary), 53 (recurrent) Nasopharynx (2) 22 (16, 33, 31, 11, X) 31 (median) n5 252, OS, DSS, DSS (oropharynx), DSS** (oral cavity) Oral cavity (84) Oropharynx (60) Hypopharynx (21) Larynx (86) Shima et al.23 46 Fixed/frozen§ Tongue (27) 74 (16, 18) —”
- Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. (2008, background): “Weight loss in last 6 mo, No. (%) 21 ) 7 (12) ≥ 10% 1 (3) 10 (18) Unknown 4 (11) 3 (5)”